A year ago, there was a lot of discussion“Triple Dilemma”Triple epidemic of influenza and bronchiolitis Coronavirus European health systems are saturated.Now China is suffering from Similar phenomenon, albeit more severe and concentrated in children.The lack of transparency from the Chinese authorities even raises doubts about what is happening in China Wuhan Just four years ago, the coronavirus outbreak hit.
The Chinese regime reiterated last Tuesday that it had “no reason to worry” about growing economic growth. respiratory infection outbreak The situation, which is plaguing the Asian country, is caused by “known pathogens” such as bacteria, according to Beijing Mycoplasma pneumoniae, which causes milder forms of SARS and causes epidemics every 4 or 6 years. Preventative measures to contain the coronavirus would have eliminated the spread of the pathogen and reduced people’s immunity to it.
If what the Chinese authorities say is true, then what happened in Europe a year ago with influenza and bronchiolitis (caused by respiratory syncytial virus) will also happen in China.Now they even claim Influenza, adenovirus, and respiratory syncytial virus have surpassed Mycoplasma pneumoniae It is the most commonly detected pathogen among patients at Beijing’s pediatric center, after some hospitals recorded long queues, sometimes with more than 10,000 patients admitted.
That him Mycoplasma pneumoniae I must go party Microbiologist predicts incidence of winter respiratory infections Mike Beatonof cardiff metropolitan university (Wales, UK) this summer.in a article Published on academic portals “dialogue” On July 13, the scientist warned that unlike respiratory syncytial virus (RSV), influenza and Streptococcus A, the Mycoplasma pneumoniae bacterium has not yet re-emerged after COVID-19, but that may change this winter . “It’s not entirely clear why it hasn’t reappeared yet. But the latest data suggests that infections may increase this winter.” The microbiologist accurately predicted.Infections rise in Ireland, Denmark and France Mycoplasma pneumoniae.
As Beaton explains in his article, Mycoplasma pneumoniaeA bacterium lacking a cell wall, discovered in 1944, can cause minor chest infections but can also lead to life-threatening illnesses such as pneumonia and brain inflammation. It is spread through droplets from an infected person’s nose and throat, and symptoms in adults are similar to the flu: sore throat, fatigue, fever, and headache. It can also cause a cough that gradually gets worse and can last for weeks or even months. Unlike the flu or COVID-19, which can take up to three weeks to develop symptoms, symptoms can appear within days of exposure to the pathogen.
infection due to Mycoplasma pneumoniae They are more common in school-age children.Your symptoms may vary and may include sneezing, stuffy or runny nose, wheezing, watery eyes, vomiting, and diarrhea. 3% to 10% of children are infected Mycoplasma pneumoniae Developed into atypical pneumonia. About 5% of these children require treatment in hospital.
Mike Beaton points out that this infection requires a special type of antibiotic, the same antibiotics used to control other bacterial infections such as tonsillitis and sinusitis.A document published this year Spanish Journal of Chemotherapy It warns that resistance to macrolide antibiotics in Mycoplasma pneumoniae is “increasing in a worrying manner around the world”, with resistance exceeding 79% in China over the past decade.led by scientists Ana Isabel Alvaro Barrerafrom the Clinical Microbiology Service University Hospital of Navarraconcluded: “More research is necessary to understand the incidence of M. pneumoniae infection and to understand the rates of macrolide resistance in our setting and in different countries.”
These antibiotic resistances may be as high as 90% in the Beijing area, “which may lead to high hospitalization rates.” Mycoplasma pneumoniae registered in China because they make treatment difficult and delay recovery from bacterial pneumonia infections,” he noted in another article for The Conversation Raul Rivasprofessor of microbiology University of Salamanca. “If infected Mycoplasma pneumoniae As appears to be happening in China, the re-emergence of this bacterium could affect a world population that has not been exposed to this bacterium in the past three years and lead to an increase in severe rare diseases and extrapulmonary symptoms,” he added.
microbiologist Maria del Mar Thomasof University Hospital of A Coruña (CHUAC), share the following hypothesis Mike Beatonaccordingly, at an unprecedented low level Mycoplasma pneumoniae, a lack of exposure to germs during the peak of the pandemic caused many people to lose immunity to the pathogen. “Strict measures against COVID-19 may lead to an increase in illnesses caused by respiratory viruses, which Mycoplasma pneumoniae The same thing happens: lack of immunity leads to more severe illness – says Mar Tomás, who is also a spokesman for the organization. Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and researcher. This does not mean that we do not monitor to avoid the risk of mutations or changes in circulating strains, but in principle this seems to be the most likely theory,” the scientists concluded.